Mayville Engineering Company, Inc.: Form 10-Q for the period ended Mar 31, 2021
Filed with the SEC on May 5, 2021 and accepted by EDGAR at May 5, 2021, 17:04 ET.
Management's discussion and analysis
As filed, 26,717 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Management’s Discussion and Analysis of Financial Condition and Results of Operations is intended to assist in the understanding and assessing the trends and significant changes in our results of operations and financial condition. Historical results may not be indicative of future performance. This discussion includes forward-looking statements that reflect our plans, estimates and beliefs. Such statements involve risks and uncertainties. Our actual results may differ materially from those contemplated by these forward-looking statements as a result of various factors, including those set forth in “Risk Factors” in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2020 and “Cautionary Statement Regarding Forward-Looking Statements” and “Risk Factors” in Part II Item 1A. of this Quarterly Report on Form 10-Q. This discussion should be read in conjunction with our audited consolidated financial statements and the notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2020 and our unaudited condensed consolidated financial statements and the notes thereto included in Part I, Item I of this Quarterly Report on Form 10-Q. In this discussion, we use certain non-GAAP financial measures. Explanation of these non-GAAP financial measures and reconciliation to the most directly comparable GAAP financial measures are included in this Management Discussion and Analysis of Financial Condition and Results of Operations. Investors should not consider non-GAAP financial measures in isolation or as substitutes for financial information presented in compliance with GAAP.
All amounts are presented in thousands except share amounts, per share data, years and ratios.
Overview
MEC is a leading U.S.-based value-added manufacturing partner that provides a broad range of prototyping and tooling, production fabrication, coating, assembly and aftermarket components. Our customers operate in diverse end markets, including heavy- and medium-duty commercial vehicles, construction & access equipment, powersports, agriculture, military and other end markets. We have developed long-standing relationships with our blue-chip customers based upon a high level of experience, trust and confidence.
Our one operating segment focuses on producing metal components that are used in a broad range of heavy- and medium-duty commercial vehicles, construction & access equipment, powersports, agricultural, military and other products.
COVID-19 Impact
COVID-19 has had and will continue to have a negative impact on our business, financial condition, cash flows, and results of operations, although the full extent is still uncertain.
For the three months ended March 31, 2021, net sales reflected the supply chain issues encountered by original equipment manufacturers’ that lead to lower production demand, which can be attributed to microchip shortages in the commercial vehicle market and port issues that impacted nearly all end markets served.
The future financial effects of COVID-19 are unknown due to many factors. These factors include uncertainty of the effectiveness of governmental actions to address COVID-19, including health, monetary and fiscal policies, the effect of elevated levels of sovereign and state debt, capital market disruptions, changes in demand and pricing, trade agreements, other geopolitical events, and the availability and volatility in the price of raw materials and other commodities. As a result, predicting the Company’s forecasted financial performance is difficult and subject to many assumptions.
The Company’s first priority has been to safeguard the health and well-being of its employees while fulfilling its obligations as an essential business serving its customer base. This proactive approach has kept employees safe and production facilities operational based on customer demand. Our goal is to continue to successfully manage through the effects of COVID-19 and strengthen our position serving customers in the future.
How We Assess Performance
Net Sales. Net sales reflect sales of our components and products net of allowances for returns and discounts. In addition to COVID-19, several factors affect our net sales in any given period, including general economic conditions, weather, timing of acquisitions and the production schedules of our customers. Net sales are recognized at the time of shipment to the customer.
Manufacturing Margins. Manufacturing margins represent net sales less cost of sales. Cost of sales consists of all direct and indirect costs used in the manufacturing process, including raw materials, labor, equipment costs, depreciation, lease expenses, subcontract costs and other directly related overhead costs. Our cost of sales is directly affected by the fluctuations in commodity prices, primarily sheet steel and aluminum, but these changes are largely mitigated by contractual agreements with our customers that allow us to pass through these price changes based upon certain market indexes.
Depreciation and Amortization. We carry property, plant and equipment on our balance sheet at cost, net of accumulated depreciation and amortization. Depreciation on property, plant and equipment is computed on a straight-line basis over the estimated useful life of the asset. Amortization expense is the periodic expense related to leasehold improvements and intangible assets. Leasehold improvements are amortized over the lesser of the life of the underlying asset or the remaining lease term. Our intangible assets were recognized as a result of certain acquisitions and are generally amortized on a straight-line basis over the estimated useful lives of the assets.
Other Selling, General, and Administrative Expenses. Other selling, general and administrative expenses consist primarily of salaries and personnel costs for our sales and marketing, finance, human resources, information systems, administration and certain other managerial employees and certain corporate level administrative expenses such as incentive compensation, audit, accounting, legal and other consulting and professional services, travel, and insurance.
Other Key Performance Indicators
EBITDA, EBITDA Margin, Adjusted EBITDA and Adjusted EBITDA Margin
EBITDA represents net income before interest expense, provision for income taxes, depreciation and amortization. EBITDA Margin represents EBITDA as a percentage of net sales for each period.
Adjusted EBITDA represents EBITDA before stock-based compensation expenses. Adjusted EBITDA Margin represents Adjusted EBITDA as a percentage of net sales for each period. These metrics are supplemental measures of our operating performance that are neither required by, nor presented in accordance with, GAAP. These measures should not be considered as an alternative to net income or any other performance measure derived in accordance with GAAP as an indicator of our operating performance. We present Adjusted EBITDA and Adjusted EBITDA Margin as management uses these measures as key performance indicators, and we believe they are measures frequently used by securities analysts, investors and other parties to evaluate companies in our industry. These measures have limitations as analytical tools and should not be considered in isolation or as substitutes for analysis of our results as reported under GAAP.
Our calculation of EBITDA, EBITDA Margin, Adjusted EBITDA and Adjusted EBITDA Margin may not be comparable to the similarly named measures reported by other companies. Potential differences between our measures of EBITDA and Adjusted EBITDA compared to other similar companies’ measures of EBITDA and Adjusted EBITDA may include differences in capital structure and tax positions.
The following table presents a reconciliation of net income, the most directly comparable measure calculated in accordance with GAAP, to Adjusted EBITDA, and the calculation of Adjusted EBITDA Margin for each of the periods presented.
| Three Months Ended March 31, 2021 | 2020 | |
|---|---|---|
| Net income | $2,545 | $50 |
| Interest expense | 532 | 826 |
| Provision for income taxes | 989 | 691 |
| Depreciation and amortization | 7,751 | 8,280 |
| EBITDA | 11,817 | 9,847 |
| IPO stock based compensation expense | — | 725 |
| Stock based compensation expense | 1,200 | 857 |
| Adjusted EBITDA | $13,017 | $11,429 |
| Net sales | $112,620 | $108,605 |
| EBITDA Margin | 10.5% | 9.1% |
| Adjusted EBITDA Margin | 11.6% | 10.5% |
20
Consolidated Results of Operations
Three Months Ended March 31, 2021 Compared to Three Months Ended March 31, 2020
| Three Months Ended March 31, 2021 Amount | % of Net Sales | 2020 Amount | % of Net Sales | Increase (Decrease) Amount Change | % Change | |
|---|---|---|---|---|---|---|
| Net sales | $112,620 | 100.0% | $108,605 | 100.0% | $4,015 | 3.7% |
| Cost of sales | 97,844 | 86.9% | 96,762 | 89.1% | 1,082 | 1.1% |
| Manufacturing margins | 14,776 | 13.1% | 11,843 | 10.9% | 2,933 | 24.8% |
| Amortization of intangibles | 2,677 | 2.4% | 2,677 | 2.5% | — | 0.0% |
| Profit sharing, bonuses and deferred compensation | 2,865 | 2.5% | 1,325 | 1.2% | 1,540 | 116.2% |
| Employee stock ownership plan expense | 473 | 0.4% | 675 | 0.6% | (202) | -29.9% |
| Other selling, general and administrative expenses | 4,695 | 4.2% | 5,599 | 5.2% | (904) | -16.1% |
| Income from operations | 4,066 | 3.6% | 1,567 | 1.4% | 2,499 | 159.5% |
| Interest expense | (532) | 0.5% | (826) | 0.8% | (294) | -35.6% |
| Provision for income taxes | 989 | 0.9% | 691 | 0.6% | 298 | 43.1% |
| Net income and comprehensive income | $2,545 | 2.3% | $50 | 0.0% | $2,495 | 4990.0% |
| EBITDA | $11,817 | 10.5% | $9,847 | 9.1% | $1,970 | 20.0% |
| Adjusted EBITDA | $13,017 | 11.6% | $11,429 | 10.5% | $1,588 | 13.9% |
Net Sales. Net sales were $112,620 for the three months ended March 31, 2021 as compared to $108,605 for the three months ended March 31, 2020, an increase of $4,015, or 3.7%. This change is primarily attributed to increasing sales volumes due to stronger market conditions in the current period and the impact of customer plant shutdowns caused by COVID-19 in the latter half of March 2020.
Manufacturing Margins. Manufacturing margins were $14,776 for the three months ended March 31, 2021 as compared to $11,843 for the three months ended March 31, 2020, an increase of $2,933, or 24.8%. The increase was driven by the aforementioned sales volume increases, utilization of our investments in new technology and automation, a reduction in overhead costs following the closure of the Greenwood, SC facility in 2020, prior period customer plant shutdowns related to COVID-19 and the initial inventory obsolescence and health care provisions of approximately $900 created in the prior period for the estimated potential impacts of COVID-19.
Manufacturing margin percentages were 13.1% for the three months ended March 31, 2021, as compared to 10.9% for the three months ended March 31, 2020, an increase of 220 basis points. This percentage change was mostly attributable to increased sales volumes coupled with the cost reduction initiatives enacted in 2020.
Amortization of Intangibles Expense. Amortization of intangibles expense was $2,677 for both the three months ended March 31, 2021 and 2020.
Profit Sharing, Bonuses and Deferred Compensation Expenses. Profit sharing, bonuses, and deferred compensation expenses were $2,865 for the three months ended March 31, 2021 as compared to $1,325 for the three months ended March 31, 2020, an increase of $1,540, or 116.2%. This change was primarily driven by the return of normalized discretionary employer 401(k) and bonus accruals as business activity and sales volumes have improved to more normalized levels.
Employee Stock Ownership Plan Expense. Employee stock ownership plan estimated expense was $473 for the three months ended March 31, 2021 as compared to $675 for the three months ended March 31, 2020, a decrease of $202, or 29.9%. The change is primarily due to the discretionary nature of contributions to the ESOP plan.
Other Selling, General and Administrative Expenses. Other selling, general and administrative expenses were $4,695 for the three months ended March 31, 2021 as compared to $5,599 for the three months ended March 31, 2020, a decrease of $904, or 16.1%. The decrease was driven by lower public company costs attributable to process improvements, continued synergies achieved through the integration of DMP, lower travel and entertainment expenses in the current period due to COVID-19 restrictions, and other cost saving initiatives.
Interest Expense. Interest expense was $532 for the three months ended March 31, 2021 as compared to $826 for the three months ended March 31, 2020, a decrease of $294, or 35.6%. The change is due to lower borrowings and interest rates during the current period as compared to the prior period.
Provision for Income Taxes. Income tax expense was $989 for the three months ended March 31, 2021 as compared to $691 for the three months ended March 31, 2020. Please reference Note 8 of the Condensed Consolidated Financial Statements for more specifics. As of March 31, 2021, our federal operating loss (NOL) carryforward was approximately $11,833 driven by the pretax losses incurred in the prior years. The NOL does not expire and will be used to offset future pretax income. We estimate our long-term effective tax rate to be approximately 26%, based on current tax regulations.
Net Income and Comprehensive Income. Net income and comprehensive income were $2,545 for the three months ended March 31, 2021 as compared to net income and comprehensive income of $50 for the three months ended March 31, 2020. The increase of $2,495 was due to the previously discussed items.
EBITDA and EBITDA Margin. EBITDA and EBITDA Margin were $11,817 and 10.5%, respectively, for the three months ended March 31, 2021 as compared to $9,847 and 9.1%, respectively, for the three months ended March 31, 2020. The $1,970 increase in EBITDA was primarily due to the increase in net sales caused by the aforementioned increase in sales volumes, utilization of our investments in new technology and automation, a reduction in overhead costs due to the closure of the Greenwood, SC facility in 2020 and the adverse impacts of COVID-19 in the prior period.
Adjusted EBITDA and Adjusted EBITDA Margin. Adjusted EBITDA and Adjusted EBITDA Margin were $13,017 and 11.6%, respectively, for the three months ended March 31, 2021, as compared to $11,429 and 10.5%, respectively, for the three months ended March 31, 2020. The increase in Adjusted EBITDA of $1,588 was primarily due to the aforementioned items discussed above and the adverse impacts of COVID-19 in the prior period.
Liquidity and Capital Resources
Cash Flows Analysis
| Three Months Ended March 31, 2021 | 2020 | Increase (Decrease) $Change | % Change | |
|---|---|---|---|---|
| Net cash provided by operating activities | $4,194 | $2,633 | 1,561 | 59.3% |
| Net cash used in investing activities | (5,255) | (2,272) | (2,983) | -131.3% |
| Net cash provided by financing activities | 1,064 | 12,639 | (11,575) | -91.6% |
| Net change in cash | $3 | $13,000 | $(12,997) | 100.0% |
Operating Activities. Cash provided by operating activities was $4,194 for the three months ended March 31, 2021, as compared to $2,633 for the three months ended March 31, 2020. The $1,561, or 59.3% increase in operating cash flows was primarily due to larger increases in net income and accounts payable, partly offset by increases in accounts receivable and inventory this quarter as compared to the prior quarter. In addition, beneficial changes in a variety of other asset and liability categories increased operating cash flows for the current period. Changes to pricing, payment terms and credit terms did not have a significant impact on changes to working capital items, or any other element of the operating cash flow activities, for the periods presented.
Investing Activities. Cash used in investing activities was $5,255 for the three months ended March 31, 2021, as compared to $2,272 for the three months ended March 31, 2020. The $2,983, or 131.3% increase in cash used in investing activities was driven by our continued investment in technology and automation in the current period as compared to leveraging our investments in new technology and automation and preserving cash during the prior year period.
Financing Activities. Cash provided by financing activities was $1,064 for the three months ended March 31, 2021, as compared to $12,639 for the three months ended March 31, 2020. The $11,575 change was primarily driven by the Company’s decision to draw down $13,000 from the revolver in the prior year period to ensure liquidity in light of the COVID-19 pandemic.
Amended and Restated Credit Agreement
On September 26, 2019, and as last amended as of March 31, 2021, we entered into the Credit Agreement with certain lenders and Wells Fargo Bank, National Association, the Agent. The Credit Agreement provides for a $200,000 Revolving Loan, with a letter of credit sub-facility in an aggregate amount not to exceed $5,000, and a swingline facility in an aggregate amount of $20,000. The Credit Agreement also provides for an additional $100,000 of capacity through an accordion feature. All amounts borrowed under the Credit Agreement mature on September 26, 2024.
Our obligations under the Credit Agreement are secured by first priority security interests in substantially all of our personal property and guaranteed by, and secured by first priority security interests in, substantially all of the personal property of, our direct and indirect subsidiaries: Center Manufacturing, Inc., Center Manufacturing Holdings, Inc., Center—Moeller Products LLC, Defiance Metal Products Co., Defiance Metal Products of Arkansas, Inc., Defiance Metal Products of PA., Inc. and Defiance Metal Products of WI, Inc.
Borrowings under the Credit Agreement bear interest at a fluctuating LIBOR (which may be adjusted for certain reserve requirements), plus 1.00% to 2.00% depending on the current Consolidated Total Leverage Ratio (as defined in the Credit Agreement). Under certain circumstances, we may not be able to pay interest based on LIBOR. If that happens, we will be required to pay interest at the Base Rate, which is the sum of (a) the higher of (i) the Prime Rate (as publicly announced by the Agent from time to time) and (ii) the Federal Funds Rate plus 0.50%, plus (b) 0.00% to 1.00%, depending on the current Total Consolidated Leverage Ratio. The Credit Agreement also includes provisions for determining a replacement rate when LIBOR is no longer available.
At March 31, 2021, the interest rate on outstanding borrowings under the Revolving Loan was 2.25%. At March 31, 2021, we had availability of approximately $153,525 under the Revolving Loan.
We must pay a commitment fee at a rate of 0.20% per annum on the average daily unused portion of the aggregate unused revolving commitments under the Credit Agreement. We must also pay fees as specified in the Fee Letter (as defined in the Credit Agreement) and with respect to any letters of credit issued under the Credit Agreement.
The Credit Agreement contains usual and customary negative covenants for agreements of this type, including, but not limited to, restrictions on our ability to, subject to certain exceptions, create, incur or assume indebtedness, create or incur liens, make certain investments, merge or consolidate with another entity, make certain asset dispositions, pay dividends or other distributions to shareholders, enter into transactions with affiliates, enter into sale leaseback transactions or make capital expenditures. The Credit Agreement also requires us to satisfy certain financial covenants, including a minimum interest coverage ratio of 3.00 to 1.00. At March 31, 2021, our interest coverage ratio was 10.85 to 1.00. The Credit Agreement also requires us to maintain a consolidated total leverage ratio not to exceed 3.25 to 1.00, although such leverage ratio can be increased in connection with certain acquisitions. This ratio was increased through the Second Amendment to the Credit Agreement to 4.00 to 1.00 for this quarter, as discussed in more detail below. As of March 31, 2021, our consolidated total leverage ratio was 1.42 to 1.00.
The Credit Agreement includes customary events of default, including, among other things, payment default, covenant default, breach of representation or warranty, bankruptcy, cross-default, material ERISA events, material money judgments, and failure to maintain subsidiary guarantees. If an event of default occurs, the Agent will be entitled to take various actions, including the acceleration of amounts due under the Credit Agreement, termination of the credit facility, and all other actions permitted to be taken by a secured creditor.
Second Amendment to the Credit Agreement
On June 30, 2020, the Company entered into the Second Amendment to the Credit Agreement. The Second Amendment provides the Company with temporary relief regarding a financial covenant (the consolidated total leverage ratio) for the period from June 30, 2020, through December 31, 2021, or such earlier date as the Company may elect (Covenant Relief Period), in return for certain increases in interest rates and fees and restrictions on certain activities of the Company, including capital expenditures, acquisitions, dividends and share repurchases. New pricing, which takes effect for the quarters ended on and after September 30, 2020, includes interest at a fluctuating LIBOR (at a floor of 75 basis points), plus 1.00% to 2.75%, along with the commitment fee ranging from 20 to 50 basis points.
During the Covenant Relief Period, the required ceiling on the Company’s consolidated total leverage ratio will be 4.25 to 1.00 for quarters ending June 30, 2020 through and including December 31, 2020 and will decline in quarterly increments to 3.25 to 1.00 for the quarter ending December 31, 2021.
As of March 31, 2021, our consolidated total leverage ratio was 1.42 to 1.00 in accordance with the Second Amendment of the Credit Agreement.
At March 31, 2021, we were in compliance with all covenants under the Credit Agreement and the Second Amendment.
Third Amendment to the Credit Agreement
On March 31, 2021, the Company entered into the Third Amendment to the Credit Agreement. The Third amendment allows the Company to incur up to $70,000 of capital expenditures during 2021, versus $35,000 in the prior period.
Capital Requirements and Sources of Liquidity
During the three months ended March 31, 2021 and 2020, our capital expenditures were $5,559 and $2,376, respectively. The increase of $3,183 was driven by our continued focus on investment in technology and automation in the current period as compared to leveraging our investments and preserving cash during the same prior year period. Capital expenditures for the full year 2021 are expected to be approximately $55,000 to $65,000. The addition of our new strategic customer is generating the requirement of $35,000 to $45,000 in additional capital investments.
We have historically relied upon cash available through credit facilities, in addition to cash from operations, to finance our working capital requirements and to support our growth. At March 31, 2021, we had immediate availability of approximately $153,525 through our Revolving Loan and another $100,000 through an accordion feature under our Credit Agreement, subject to the covenants under the Credit Agreement and Second Amendment. We regularly monitor potential capital sources, including equity and debt financings, in an effort to meet our planned capital expenditures and liquidity requirements. Our future success will be highly dependent on our ability to access outside sources of capital. We will continue to have access to the availability currently provided under the Credit Agreement as long as we remain compliant with the financial covenants. Based on our estimates of the impact of COVID-19 at this time, we expect to be in compliance with these financial covenants through 2021 and the foreseeable future.
We believe that our operating cash flow and available borrowings under the Credit Agreement are sufficient to fund our operations for 2021 when taking into consideration the estimated impacts of COVID-19 based on the information we have available at this time. However, future cash flows are subject to a number of variables, and additional capital expenditures will be required to conduct our operations. There can be no assurance that operations and other capital resources will provide cash in sufficient amounts to maintain planned or future levels of capital expenditures. In the event we make one or more acquisitions and the amount of capital required is greater than the amount we have available for acquisitions at that time, we could be required to reduce the expected level of capital expenditures and/or seek additional capital. If we seek additional capital, we may do so through borrowings under the Credit Agreement, joint ventures, asset sales, offerings of debt or equity securities or other means. We cannot guarantee that this additional capital will be available on acceptable terms or at all. If we are unable to obtain the funds we need, we may not be able to complete acquisitions that may be favorable to us or finance the capital expenditures necessary to conduct our operations.
Contractual Obligations
The following table presents our obligations and commitments to make future payments under contracts and contingent commitments at March 31, 2021:
| Total | Payments Due by Period 2021 (Remainder) | 2022 – 2023 | 2024 – 2025 | Thereafter | |
|---|---|---|---|---|---|
| Long-term debt principal payment obligations (1) | $46,475 | $— | $— | $46,475 | $— |
| Forecasted interest on debt payment obligations (2) | 5,003 | 1,072 | 2,859 | 1,072 | — |
| Capital lease obligations | 2,759 | 551 | 1,468 | 740 | — |
| Operating lease obligations | 12,389 | 2,496 | 4,998 | 2,679 | 2,216 |
| Total | $66,626 | $4,119 | $9,325 | $50,966 | $2,216 |
(1) The long-term amounts in the table include principal payments under the Company’s Credit Agreement, which expires in 2024.
(2) Forecasted interest on debt obligations based on the debt balance, interest rate and unused fee as of March 31, 2021.
Market risk
As filed, 2,395 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
We are exposed to market risk from changes in customer forecasts, interest rates, and, to a lesser extent, commodities. To reduce such risks, we selectively use financial instruments and other proactive management techniques.
Customer Forecasts
The use and consumption of our components, products and services fluctuates depending on order forecasts we receive from our customers. These order forecasts can change dramatically from quarter-to-quarter dependent upon the respective markets that our customers provide products in.
Interest Rate Risk
We are exposed to interest rate risk on certain of our short- and long-term debt obligations used to finance our operations and acquisitions. We have LIBOR-based floating rate borrowings under the Credit Agreement, which exposes us to variability in interest payments due to changes in the referenced interest rates.
The amount borrowed under the Revolver Loan under the Credit Agreement was $46.5 million as of March 31, 2021. The interest rate was 2.25% as of March 31, 2021. Please see “Liquidity and Capital Resources - Amended and Restated Credit Agreement” in Part I, Item 2 of this Quarterly Report on Form 10-Q and Note 3 in the Notes to the Unaudited Condensed Consolidated Financial Statements for more specifics.
A hypothetical 100-basis-point increase in interest rates would have resulted in an additional $0.1 million of interest expense based on our variable rate debt at March 31, 2021. We do not use derivative financial instruments to manage interest risk or to speculate on future changes in interest rates. A rise in interest rates could negatively affect our cash flow.
Commodity Risk
We source a wide variety of materials and components from a network of suppliers. While such materials are generally available from numerous suppliers, COVID-19 has resulted in availability delays at times. In addition, commodity raw materials, such as steel, aluminum, copper, paint and paint chemicals, and other production costs are subject to price fluctuations, which could have a negative impact on our results. We strive to pass along such commodity price increases to customers to avoid profit margin erosion and in many cases utilize contracts with those customers to mitigate the impact of commodity raw material price fluctuations. As of March 31, 2021, we did not have any commodity hedging instruments in place.
Controls and procedures
As filed, 2,039 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Evaluation of Disclosure Controls and Procedures
We maintain disclosure controls and procedures that are designed to provide reasonable assurance that information required to be disclosed in the reports we file or submit under the Securities Exchange Act of 1934, as amended (the Exchange Act), is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure. In designing disclosure controls and procedures, our management was required to apply its judgment in evaluating the cost-benefit relationship of possible disclosure controls and procedures. The design of any disclosure controls and procedures also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired objectives.
Our management, under the supervision of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of the end of the period covered by this Quarterly Report on Form 10-Q and has concluded that, as of the end of such period, our disclosure controls and procedures were effective at the reasonable assurance level.
Changes in Internal Control Over Financial Reporting
There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act during the three months ended March 31, 2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Risk factors
As filed, 231 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
There have been no material changes to the risk factors previously disclosed in Part I, Item 1A, “Risk Factors,” in our Annual Report on Form 10-K for the year ended December 31, 2020, which was filed with the SEC on March 5, 2021.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2021-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2021-01-01 to 2021-03-31 | $112.6m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2021-01-01 to 2021-03-31 | $97.8m | us-gaap:CostOfRevenue |
| Operating income | 3 months2021-01-01 to 2021-03-31 | $4.1m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2021-01-01 to 2021-03-31 | $532.0k | us-gaap:InterestExpense |
| Income tax | 3 months2021-01-01 to 2021-03-31 | $989.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2021-01-01 to 2021-03-31 | $2.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2021-01-01 to 2021-03-31 | $0.12 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2021-01-01 to 2021-03-31 | $0.13 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2021-01-01 to 2021-03-31 | 20,667,684 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2021-01-01 to 2021-03-31 | $4.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2021-01-01 to 2021-03-31 | $5.6m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2021-03-31 | $124.0k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2021-03-31 | $107.6m | us-gaap:AssetsCurrent |
| Total assets | At period end2021-03-31 | $353.8m | us-gaap:Assets |
| Current liabilities | At period end2021-03-31 | $61.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2021-03-31 | $147.2m | us-gaap:Liabilities |
| Shareholders' equity | At period end2021-03-31 | $206.5m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001564590-21-024186. Last ingested by Listed: Nov 5, 2026, 13:59 ET. Listed shows no prices and gives no investment advice.